鹭燕医药：控股股东2252.38万股解除质押

Core Viewpoint - The announcement indicates that the controlling shareholder, Maidiken, has released a portion of its pledged shares in Luyan Pharmaceutical, which may reflect a positive outlook on the company's financial health and stability [1] Group 1: Share Pledge Details - Maidiken has released 22.5238 million shares, which accounts for 16.32% of its held shares and 5.80% of the company's total share capital [1] - The pledge release started on November 2, 2020, and will end on October 31, 2025 [1] - The pledge was held by the Industrial and Commercial Bank of China, Xiamen Heshan Branch [1] Group 2: Current Pledge Status - As of the announcement date, Maidiken and its concerted parties have pledged a total of 0 shares [1]